Lithuanian Atletes' Aortic Diameter
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03656861 |
Recruitment Status :
Completed
First Posted : September 4, 2018
Last Update Posted : September 5, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Sports Accident Athletes Heart | Other: Physical load |
A preliminary data was collected from a total of 944 subjects in Kaunas Sports Medicine Centre during the recruiting period in 2014-2015. Final data analysis consisted of 151 Caucasian subjects who met the inclusion criteria.
All subjects underwent two-dimensional (2D) transthoracic echocardiography (TTE) procedure. Prior to performing 2D TTE, subjects' arterial blood pressure, heart rate, height, weight, and self-reported physical activity levels were measured.
The Ultrasound system CX50 (Philips Ultrasound, Philips Healthcare, Philips Medical Systems Nederland, USA) - with transducer S5-1 was used in this study. Two physicians performed 2D TTE and averages for all variables of interest were computed. The measurements of aortic root and the left ventricle were drawn upon the guidelines of the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
The maximal diameter of the sinuses of Valsalva was measured at end-diastole, in a strictly perpendicular plane to that of the long axis of the aorta using the edge to leading edge (L-L) convention. The aortic annulus was measured at midsystole from inner edge to inner edge (I-I). This was done in order to obtain the rounder shape and bigger diameter of aortic annulus.
Study Type : | Observational |
Actual Enrollment : | 151 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Retrospective |
Official Title: | Lithuanian Athletes' Aortic Root Diameter |
Actual Study Start Date : | September 1, 2014 |
Actual Primary Completion Date : | September 30, 2015 |
Actual Study Completion Date : | September 30, 2015 |
Group/Cohort | Intervention/treatment |
---|---|
Athletes
122 were athletes (41 females and 81 males). Of the 41 female athletes, 32 were endurance athletes, and 9 strength athletes. From 81 male athletes, 56 were endurance athletes, and 25 were strength athletes.
|
Other: Physical load
The impact of training on cardiac structure and function depends on the type, intensity and duration of the activity, as well as previous physical activity engagement, genetics and gender type. More knowledge about cardiac pathophysiologic training adaptation is needed. |
Non-athletes
29 were non-athletes (14 females and 15 males)
|
- Measurement of aortic root at aortic valve annulus (AA) [ Time Frame: Long-term adaptation more when 4 years of physical activity with 4.5 hours per week training sessions ]Changes in aortic root at aortic valve annulus (AA) and at individuals.
- Measurement of aortic root at sinus of Valsalva (VS) [ Time Frame: Long-term adaptation more when 4 years of physical activity with 4.5 hours per week training sessions ]Changes in aortic root at sinus of Valsalva (VS) individuals.
- Measurement of values of the left ventricle (LV): LV end-diastolic diameter (LVEDD) [ Time Frame: Long-term adaptation more when 4 years of physical activity with 4.5 hours per week training sessions ]Changes values of the left ventricle (LV): LV end-diastolic diameter (LVEDD)
- Measurement of values of interventricular septum thickness in diastole (IVSTd) [ Time Frame: Long-term adaptation more when 4 years of physical activity with 4.5 hours per week training sessions ]Changes values of interventricular septum thickness in diastole (IVSTd)
- LV posterior wall thickness in diastole (LVPWTd) [ Time Frame: Long-term adaptation more when 4 years of physical activity with 4.5 hours per week training sessions ]Changes values of LV posterior wall thickness in diastole (LVPWTd)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years to 35 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- A total of 2D transthoracic echocardiography performed in Kaunas Sports Medicine Centre 2014-2015.
- Age range 16- 35 years, given the literature definition of 'young' and 'old' athletes as < 35 and > 35 years.
- Physical activity levels (athletes or non-athletes). Individuals who participated in sports for more than 4 years and 4.5 hours per week were included in the group of athletes. Individual who were active for less than 4 years and/or 4.5 hours per week were classified as non-athletes.
- Physical activity type (endurance and strength sports).
- No current or previous history cardiovascular diseases.
- No activity on the test day.
- Consent to participate in the study.
Exclusion Criteria:
- No 2D transthoracic echocardiography.
- Age below 16 or over 35.
- Involvement in sports for less than 4 years and 4.5 hours per week.
- Sports branches not included in the list of endurance or strength sports (i.e., sprint, high jump, etc.).
- Cardiovascular disease (i.e., hypertonic disease, Marfan syndrome, bicuspid aortic valve, detected cardiomyopathy, etc.).
- Physical activity on the echocardiography test day.
- No content to participate in the study.
Responsible Party: | Agne Slapsinskaite, Principal Investigator, Institut Nacional d'Educacio Fisica de Catalunya |
ClinicalTrials.gov Identifier: | NCT03656861 |
Other Study ID Numbers: |
Kaunas Sport Medicine Centre |
First Posted: | September 4, 2018 Key Record Dates |
Last Update Posted: | September 5, 2018 |
Last Verified: | August 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Aortic Valve Sinus of Valsalva Echocardiography Sudden cardiac death |